Cardiovascular Surgical Devices Market – Size, Trends, and Forecast to 2033

The global cardiovascular surgical devices market is projected to grow from US$ 2.11 billion in 2024 to US$ 2.86 billion by 2033, reflecting a CAGR of 3.45% during 2024–2033. Growth is driven by the rising prevalence of cardiovascular diseases (CVDs), rapid advancements in surgical technologies, and increasing adoption of minimally invasive procedures—making these devices critical in improving global cardiac healthcare outcomes.

The report Cardiovascular Surgical Devices Market & Forecast analyzes the industry by Product Type (Beating Heart Surgery Systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables), Application (Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Others), End-User (Hospitals, Ambulatory Surgical Centers, Others), along with Country-Level and Company Analysis for 2025–2033.

Market Overview

Cardiovascular surgical devices are specialized tools used to diagnose, treat, and manage heart and vascular conditions via surgical interventions. These devices address conditions such as coronary artery disease, arrhythmias, heart valve disorders, aneurysms, and congenital heart defects.

Common devices include:

·        Heart-lung machines – Maintain circulation and oxygenation during open-heart surgery.

·        Stents & grafts – Restore blood flow in blocked or weakened arteries.

·        Pacemakers & implantable defibrillators – Regulate abnormal heart rhythms.

·        Catheters – Enable minimally invasive procedures like angioplasty.

·        Artificial heart valves – Replace damaged valves.

The widespread use of these devices has transformed cardiac care—shortening recovery times, reducing complications, and improving patient survival rates.

Key Growth Drivers

1. Increasing Prevalence of Cardiovascular Diseases

CVDs are the leading cause of death worldwide, claiming 20.5 million lives in 2021—nearly one-third of all global deaths. Sedentary lifestyles, poor diet, obesity, and diabetes are major contributors, increasing demand for surgical interventions like CABG (coronary artery bypass grafting) and valve repair. Government healthcare programs targeting CVD management further fuel the adoption of advanced surgical devices.

2. Advancements in Surgical Technology

Technological innovations, including robotic-assisted surgeries, catheter-based interventions, bioresorbable stents, 3D-printed heart valves, and next-generation pacemakers, are improving precision, reducing recovery times, and enhancing patient outcomes. Artificial intelligence (AI) is increasingly integrated into cardiovascular diagnostics and surgical planning.
Example: In October 2024, Royal Philips introduced new cardiology solutions at TCT to enhance clinical confidence and procedural efficiency.

3. Growing Geriatric Population

Older adults are at higher risk of heart disease due to age-related changes in heart and vascular health. With 10.3% of the world’s population aged 65+ in 2024 (expected to triple for 80+ by 2050), the demand for advanced cardiac surgical interventions will continue to rise, particularly in specialized cardiac care centers.

Market Challenges

·        High Device & Procedure Costs: Premium technologies such as robotic systems and bioengineered implants have high acquisition and maintenance costs, limiting adoption in developing economies.

·        Stringent Regulatory Approvals: Lengthy and complex approval processes from agencies like FDA and EMA slow innovation and global market expansion.

·        Unequal Accessibility: Inconsistent healthcare infrastructure and insurance coverage restrict adoption in low-resource settings.

Get Customization in the Report: https://www.renub.com/request-customization-page.php?gturl=cardiovascular-surgical-device-market-p.php

Segment Insights

By Product Type

·        Beating Heart Surgery Systems

·        Cardiopulmonary Bypass Equipment

·        Cardiac Ablation Devices

·        Perfusion Disposables

By Application

·        Congenital Heart Defects

·        Cardiac Arrhythmia

·        Coronary Heart Disease

·        Congestive Heart Failure

·        Others

By End-User

·        Hospitals

·        Ambulatory Surgical Centers

·        Others

Key Sub-Segments

·        Perfusion Disposables: Vital for maintaining blood flow during cardiac procedures such as bypass surgeries, driving continuous demand.

·        Coronary Heart Disease Devices: With CHD being a top global killer, stents, catheters, and grafts remain high-demand products.

·        Hospitals: The primary end-user segment, equipped with advanced technologies for high-volume cardiac surgeries.

Regional Insights

United States

Dominates the global market due to high CVD prevalence, advanced healthcare infrastructure, and high adoption of premium surgical devices. Heart disease remains the leading cause of death, with 697,000 deaths annually.

France

Strong focus on minimally invasive surgeries and R&D, supported by government initiatives. The country’s aging population and high CVD incidence drive demand for advanced devices.

India

Rapid market growth fueled by rising CVD cases, medical tourism, and increasing acceptance of innovative devices. However, affordability and rural accessibility remain challenges.
Example: In Dec 2023, Terumo India launched the “Ultimate Nagomi” drug-eluting stent for diverse artery sizes.

Saudi Arabia

Market growth is supported by Vision 2030 healthcare investments, rising CVD rates from lifestyle diseases, and adoption of minimally invasive procedures.
Example: In May 2024, Bayer and Huma Therapeutics launched a new heart health screening tool in the country.

Key Companies in the Global Market

·        Abbott Laboratories

·        Boston Scientific Corporation

·        Edwards Lifesciences

·        Cardinal Health Inc.

·        Medtronic PLC

·        GE Healthcare

·        LivaNova PLC

·        Terumo Corporation

About the Company

Renub Research is a Market Research and Consulting Company with over 15 years of experience in international B2B research, surveys, and consulting. We deliver data-driven business research solutions that enable companies to make informed decisions, uncover high-value opportunities, and address strategic challenges.

Our clients span industries such as Healthcare, Travel & Tourism, Food & Beverages, Power & Energy, IT & Telecom, Chemicals, Logistics, Automotive, Consumer Goods, Construction, and Agriculture. Our expert team includes professionals with advanced degrees (MBA, Ph.D., MSc) in diverse fields such as Finance, Marketing, Biotechnology, Medicine, and Environmental Science.

Contact Us:
Company Name: Renub Research
Contact Person: Rajat Gupta
Phone: (D) +91-120-421-9822 (IND)
Email: rajat@renub.com